Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer Immunol Res. 2017 Jan 11;5(2):127–136. doi: 10.1158/2326-6066.CIR-16-0293

Figure 6. Allogeneic CD4+ T cells could not help CD8+ T cells eradicate tumors in the absence of MHCII expression by the host.

Figure 6

PRO4L-SIY-EGFP tumor-bearing MHCII−/− Rag−/− B6 mice were treated with sorted 2C CD8+ T cells (arrows) and sorted CD4+ T cells from CD8−/− B6 mice at the indicated times (red dots). Data were pooled from 3 independent experiments. Only 1/7 total mice rejected the tumor.